Silver Book Fact

The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.

Murphy K, Topel R. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003. https://press.uchicago.edu/ucp/books/book/chicago/M/bo3643529.html

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy K, Topel R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • There are currently 312 medicines in development for heart disease and stroke.  
  • There are 23 medicines in development for stroke, the third leading cause of death after heart disease and cancer.  
  • In the absence of antihypertensive drug therapy, there would have been an estimated 572,000 more hospital discharges for stroke in 2002, and 261,000 more discharges for myocardial infarction. The…  
  • The volume of mitral valve surgical procedures increased approximately 8.3% from 2010 to 2013.